MondayMay 20, 2024 1:21 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will participate in a fireside chat at the Healthcare Company Showcase hosted by Alliance Global Partners. Climaco’s presentation is slated to begin at 1:40 p.m. ET on May 21, 2024. A live webcast will be available on the Events page of CNSP’s website. To view the full press release, visit https://ibn.fm/OSiDy About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company…

Continue Reading

MondayMay 20, 2024 11:52 am

TinyGemsBreaks – NextPlat Corp’s (NASDAQ: NXPL) GTC Begins Sales of SpaceX’s Starlink as Authorized Reseller

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that its subsidiary, Global Telesat Communications Ltd (“GTC”), through a new joint venture agreement with Pivotel Solutions Inc. (dba “Pulsar”) is now a global authorized reseller of SpaceX’s Starlink satellite-based connectivity products. Under the agreement as as an approved reseller, GTC will immediately begin offering Starlink connectivity services in the U.K. and other international markets serving mobile and maritime-based customers. Pulsar will provide GTC back-end systems support services on behalf of its new Starlink customers. “We are pleased to collaborate with Pulsar to begin offering SpaceX’s revolutionary Starlink, LEO-satellite based…

Continue Reading

FridayMay 17, 2024 2:46 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of Dosing in Comprehensive GLP-1 Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, reported that dosing has begun in its 12-week animal study, WEIGHT-A24-1. The study is designed to model diabetes treatment and weight-loss effects of DehydraTECH(TM)-processed glucagon-like peptide 1 drugs and DehydraTECH-processed cannabidiol (“CBD”), both alone and in combination in diabetic preconditioned rats. According to the announcement, several new areas of investigation are being explored in this study, including evaluating whether DehydraTECH-processed oral GLP-1 drugs are more effective than non-DehydraTECH-processed oral GLP-1 drugs in reaching brain tissue, improving weight loss and improving control of blood sugar. The study will also evaluate…

Continue Reading

ThursdayMay 16, 2024 3:22 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has proven in numerous studies the ability of its patented DehydraTECH(TM) technology to increase bio-absorption compared to standard industry formulations, as well as reduce time of onset and deliver drugs more effectively across the blood-brain barrier. “DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The key factor that has played a role in its adoption is its unique ability to improve drug bioavailability, a critical marker and determinant of overall drug effectiveness,” a recent article reads. “With this technology, Lexaria…

Continue Reading

ThursdayMay 16, 2024 2:31 pm

TinyGemsBreaks – Armlogi Holding Corp. (NASDAQ: BTOC) Announces Public Offering Pricing

Armlogi Holding (NASDAQ: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, has released the pricing of its initial public offering. The offering is comprised of 1,600,000 shares of common stock at $5 per share, resulting in gross proceeds of $8 million for the company, before the deduction of underwriting discounts and offering expenses. According to the announcement, Armlogi Holding also granted a 45-day option to underwriters to purchase up to 240,000 additional shares of common stock to cover any overallotments. EF Hutton LLC is acting…

Continue Reading

ThursdayMay 16, 2024 2:00 pm

TinyGemsBreaks – Sow Good Inc. (NASDAQ: SOWG) Closes Overallotment Option in $13.8M Public Offering

Sow Good (NASDAQ: SOWG), a trailblazer in the freeze dried candy and treat industry, recently announced that the underwriters of its completed public offering of common stock had purchased 180,000 shares of its common stock. The underwriters made the purchase upon full exercise of their option to purchase additional shares of common stock to cover overallotments at the initial offering price of $10.00 per unit. Including proceeds from the sale of additional shares, the offering yielded approximately $13.8 million in gross proceeds before deductions. Roth Capital Partners acted as sole book-running manager for the offering, while Craig-Hallum acted as the…

Continue Reading

ThursdayMay 16, 2024 1:56 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting its financial and business results for the first quarter 2024, the period ended March 31, 2024. A highlight of the report was that enrollment is nearly completed in a potentially pivotal GBM study evaluating Berubicin with topline data expected in the first half of 2025. In addition, financial results showed a net loss for the quarter of approximately $3.5 million, down from an estimated $4.9 million net loss for the comparable period…

Continue Reading

ThursdayMay 16, 2024 10:56 am

TinyGemsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) CEO Shares Shareholder Letter, Corporate Update

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, and its chair and CEO Robert Nistico have released a letter to shareholders. In the letter, Nistico shared information from the company’s first-quarter 2024 results, along with a corporate update. Notable numbers from the quarter include sales of $1.2 million from the company’s branded beverage division, down from $1.9 million over the same period last year, with the company’s eCommerce division, Qplash, reporting shipments “well below” demand and capabilities. Nistico provided an explanation for the lower numbers, noting that the company reports revenue from shipments to distributors, which typically maintain…

Continue Reading

WednesdayMay 15, 2024 1:37 pm

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Announces Record Consolidated Q1 2024 Revenues, Improved Quarterly Margins

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced record financial results for the first fiscal quarter ended March 31, 2024, which includes the consolidation of the operations of its e-commerce business with the results of its healthcare operations, Progressive Care Inc. (OTCQB: RXMD). “First quarter results continued to demonstrate the fundamental strength of NextPlat’s focus on the large healthcare services and global e-commerce technology markets and further demonstrates our team execution against its global growth plans,” said Charles M. Fernandez, executive chairman and CEO of NextPlat Corp. “Throughout the remainder of 2024, we are committed to maximizing and…

Continue Reading

WednesdayMay 15, 2024 12:43 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Q2 2024 Financial, Business Result; Announces Expansion of Commercial EV Dealer Network

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, is reporting on the financial results and business highlights for the three and six months ended March 31, 2024. Key achievements during the quarter include receiving approval from the U.S. Department of Commerce for Foreign Trade Zone status at its Tunica, Mississippi, commercial vehicle manufacturing facility; adding national and regional fleet focus in the Midwest and West Coast and expanding its retail commercial dealer network with the addition of Pritchard EVs and National Auto Fleet Group; and receiving California Air Resource Board’s (“CARB”) HVIP approval for the Mullen THREE, Class 3…

Continue Reading

Contact us: (512) 354-7000